REPORT ID 5206

EMEA (Europe, Middle East and Africa) Implantable Neurostimulation Devices Market Report 2019

Publish Date
2019
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Implantable Neurostimulation Devices market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Implantable Neurostimulation Devices for these regions, from   2019 to 2025 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Implantable Neurostimulation Devices market competition by top manufacturers/players, with Implantable Neurostimulation Devices sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    St. Jude Medical (US)
    Medtronic (US)
    Boston Scientific (US)
    BioControl Medical (Israel)
    Synapse Biomedical (US)
    Nevro Corporation (US)
    Spinal Modulation (US)
    Cyberonics (US)

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Spinal Cord Stimulation (SCS)
    Deep Brain Stimulation (DBS)
    Sacral Nerve Stimulation (SNS)
    Gastric Electric Stimulation (GES)
    Vagus Nerve Stimulation (VNS)
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Clinics
    Ambulatory Surgical Centers
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Implantable Neurostimulation Devices Market  Report 2019
1 Implantable Neurostimulation Devices Overview
    1.1 Product Overview and Scope of Implantable Neurostimulation Devices
    1.2 Classification of Implantable Neurostimulation Devices
        1.2.1 EMEA Implantable Neurostimulation Devices Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 EMEA Implantable Neurostimulation Devices Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Spinal Cord Stimulation (SCS)
        1.2.4 Deep Brain Stimulation (DBS)
        1.2.5 Sacral Nerve Stimulation (SNS)
        1.2.6 Gastric Electric Stimulation (GES)
        1.2.7 Vagus Nerve Stimulation (VNS)
        1.2.8 Other
    1.3 EMEA Implantable Neurostimulation Devices Market by Application/End Users
        1.3.1 EMEA Implantable Neurostimulation Devices Sales (Volume) and Market Share Comparison by Application ( 2014-2024
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Ambulatory Surgical Centers
        1.3.5 Other
    1.4 EMEA Implantable Neurostimulation Devices Market by Region
        1.4.1 EMEA Implantable Neurostimulation Devices Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 Europe Status and Prospect ( 2014-2024)
        1.4.3 Middle East Status and Prospect ( 2014-2024)
        1.4.4 Africa Status and Prospect ( 2014-2024)
    1.5 EMEA Market Size (Value and Volume) of Implantable Neurostimulation Devices ( 2014-2024)
        1.5.1 EMEA Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2024)
        1.5.2 EMEA Implantable Neurostimulation Devices Revenue and Growth Rate ( 2014-2024)

2 EMEA Implantable Neurostimulation Devices Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Implantable Neurostimulation Devices Market Competition by Players/Manufacturers
        2.1.1 EMEA Implantable Neurostimulation Devices Sales Volume and Market Share of Major Players ( 2014-2019)
        2.1.2 EMEA Implantable Neurostimulation Devices Revenue and Share by Players ( 2014-2019)
        2.1.3 EMEA Implantable Neurostimulation Devices Sale Price by Players ( 2014-2019)
    2.2 EMEA Implantable Neurostimulation Devices (Volume and Value) by Type/Product Category
        2.2.1 EMEA Implantable Neurostimulation Devices Sales and Market Share by Type ( 2014-2019)
        2.2.2 EMEA Implantable Neurostimulation Devices Revenue and Market Share by Type ( 2014-2019)
        2.2.3 EMEA Implantable Neurostimulation Devices Sale Price by Type ( 2014-2019)
    2.3 EMEA Implantable Neurostimulation Devices (Volume) by Application
    2.4 EMEA Implantable Neurostimulation Devices (Volume and Value) by Region
        2.4.1 EMEA Implantable Neurostimulation Devices Sales and Market Share by Region ( 2014-2019)
        2.4.2 EMEA Implantable Neurostimulation Devices Revenue and Market Share by Region ( 2014-2019)
        2.4.3 EMEA Implantable Neurostimulation Devices Sales Price by Region ( 2014-2019)

3 Europe Implantable Neurostimulation Devices (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Implantable Neurostimulation Devices Sales and Value ( 2014-2019)
        3.1.1 Europe Implantable Neurostimulation Devices Sales Volume and Growth Rate ( 2014-2019)
        3.1.2 Europe Implantable Neurostimulation Devices Revenue and Growth Rate ( 2014-2019)
    3.2 Europe Implantable Neurostimulation Devices Sales and Market Share by Type
    3.3 Europe Implantable Neurostimulation Devices Sales and Market Share by Application
    3.4 Europe Implantable Neurostimulation Devices Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Implantable Neurostimulation Devices Sales Volume by Countries ( 2014-2019)
        3.4.2 Europe Implantable Neurostimulation Devices Revenue by Countries ( 2014-2019)
        3.4.3 Germany Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        3.4.4 France Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        3.4.5 UK Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        3.4.6 Russia Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        3.4.7 Italy Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        3.4.8 Benelux Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)

4 Middle East Implantable Neurostimulation Devices (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Implantable Neurostimulation Devices Sales and Value ( 2014-2019)
        4.1.1 Middle East Implantable Neurostimulation Devices Sales Volume and Growth Rate ( 2014-2019)
        4.1.2 Middle East Implantable Neurostimulation Devices Revenue and Growth Rate ( 2014-2019)
    4.2 Middle East Implantable Neurostimulation Devices Sales and Market Share by Type
    4.3 Middle East Implantable Neurostimulation Devices Sales and Market Share by Application
    4.4 Middle East Implantable Neurostimulation Devices Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Implantable Neurostimulation Devices Sales Volume by Countries ( 2014-2019)
        4.4.2 Middle East Implantable Neurostimulation Devices Revenue by Countries ( 2014-2019)
        4.4.3 Saudi Arabia Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        4.4.4 Israel Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        4.4.5 UAE Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        4.4.6 Iran Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)

5 Africa Implantable Neurostimulation Devices (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Implantable Neurostimulation Devices Sales and Value ( 2014-2019)
        5.1.1 Africa Implantable Neurostimulation Devices Sales Volume and Growth Rate ( 2014-2019)
        5.1.2 Africa Implantable Neurostimulation Devices Revenue and Growth Rate ( 2014-2019)
    5.2 Africa Implantable Neurostimulation Devices Sales and Market Share by Type
    5.3 Africa Implantable Neurostimulation Devices Sales and Market Share by Application
    5.4 Africa Implantable Neurostimulation Devices Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Implantable Neurostimulation Devices Sales Volume by Countries ( 2014-2019)
        5.4.2 Africa Implantable Neurostimulation Devices Revenue by Countries ( 2014-2019)
        5.4.3 South Africa Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        5.4.4 Nigeria Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        5.4.5 Egypt Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)
        5.4.6 Algeria Implantable Neurostimulation Devices Sales and Growth Rate ( 2014-2019)

6 EMEA Implantable Neurostimulation Devices Manufacturers/Players Profiles and Sales Data
    6.1 St. Jude Medical (US)
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 St. Jude Medical (US) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.1.4 Main Business/Business Overview
    6.2 Medtronic (US)
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Medtronic (US) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.2.4 Main Business/Business Overview
    6.3 Boston Scientific (US)
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Boston Scientific (US) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.3.4 Main Business/Business Overview
    6.4 BioControl Medical (Israel)
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 BioControl Medical (Israel) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.4.4 Main Business/Business Overview
    6.5 Synapse Biomedical (US)
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Synapse Biomedical (US) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.5.4 Main Business/Business Overview
    6.6 Nevro Corporation (US)
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Nevro Corporation (US) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.6.4 Main Business/Business Overview
    6.7 Spinal Modulation (US)
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Spinal Modulation (US) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.7.4 Main Business/Business Overview
    6.8 Cyberonics (US)
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Implantable Neurostimulation Devices Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Cyberonics (US) Implantable Neurostimulation Devices Sales, Revenue, Price and Gross Margin ( 2014-2019)
        6.8.4 Main Business/Business Overview

7 Implantable Neurostimulation Devices Manufacturing Cost Analysis
    7.1 Implantable Neurostimulation Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Implantable Neurostimulation Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Implantable Neurostimulation Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Implantable Neurostimulation Devices Major Manufacturers  in 2018
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Implantable Neurostimulation Devices Market Forecast ( 2019-2025)
    11.1 EMEA Implantable Neurostimulation Devices Sales, Revenue and Price Forecast ( 2019-2025)
        11.1.1 EMEA Implantable Neurostimulation Devices Sales and Growth Rate Forecast ( 2019-2025)
        11.1.2 EMEA Implantable Neurostimulation Devices Revenue and Growth Rate Forecast ( 2019-2025)
        11.1.3 EMEA Implantable Neurostimulation Devices Price and Trend Forecast ( 2019-2025)
    11.2 EMEA Implantable Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.3 Europe Implantable Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.4 Middle Eastt Implantable Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.5 Africa Implantable Neurostimulation Devices Sales, Revenue and Growth Rate Forecast by Region ( 2019-2025)
    11.6 EMEA Implantable Neurostimulation Devices Sales Forecast by Type ( 2019-2025)
    11.7 EMEA Implantable Neurostimulation Devices Sales Forecast by Application ( 2019-2025)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer